Santé & Pharma

PIU’ MEDICAL COMUNICAZIONE INTERMEDIA DURANTE IL PERIODO DI STABILIZZAZIONE

34,9M

PIU’ MEDICAL INTERIM COMMUNICATION DURING THE STABILIZATION PERIOD

269,8M

PIU’ MEDICAL PIÙ MEDICAL AMMESSA ALLE NEGOZIAZIONI SU EURONEXT GROWTH MILAN

34,9M

PIU’ MEDICAL SPA

32,4M

PLx Pharma Inc.

PMV Pharmaceuticals, Inc.

69,6M

PNV

604,5M

POD

40,8M

POINT Biopharma Global Inc.

POLARITYTE, INC.

POXEL

13M

PPD, Inc.

PPD, Inc.

PRA Health Sciences, Inc.

PREDILIFE

4,5M

PRIM S.A

PRIM, S.A.

225,4M

PRIM, S.A.

4,7B

PRO DEX INC

209,3M

PRO MEDEX

290,5M

PROCEPT BioRobotics Corp

1,2B

PROCYON CORP

2M

PROGENITY, INC.

PSYCHEMEDICS CORP

15,2M

PTC Therapeutics, INC.

6,1B

PZ Cormay S.A.

44,5M

Pacific Biosciences of California, INC.

403,8M

Pacific Health Care Organization INC

11M

Pacira BioSciences, Inc.

984,5M

Palatin Technologies INC

14M

Palisade Bio, INC.

366,7M

Panacea Biotec Limited

25,8B

Panacea Life Sciences Holdings, INC.

1,6M

Panbela Therapeutics, Inc.

53,9k

Paragon 28, Inc.

Paratek Pharmaceuticals, Inc.

Pardes Biosciences, INC.

Park Dental Partners, Inc.

87,9M

Pasithea Therapeutics Corp.

Passage BIO, Inc.

15,5M

Patterson Companies, INC.

Paxman AB (publ)

1,1B

Paxman AB (publ)

1,1B

Peak Processing Limited

21,4M

Pear Therapeutics, Inc.

Pediatrix Medical Group, Inc.

2,2B

Peijia Medical Ltd. - B

2,9B

Pelthos Therapeutics Inc.

98,6M

Pennant Group, Inc.

1,4B

Pentixapharm Holding AG

45,8M